Vigilare Wealth Management’s Xtrackers MSCI EAFE Hedged Equity ETF DBEF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$323K Hold
5,910
0.1% 92
2026
Q1
$292K Hold
5,910
0.1% 87
2025
Q4
$284K Hold
5,910
0.1% 98
2025
Q3
$274K Hold
5,910
0.1% 103
2025
Q2
$259K Hold
5,910
0.1% 98
2025
Q1
$256K Hold
5,910
0.1% 84
2024
Q4
$245K Hold
5,910
0.1% 78
2024
Q3
$248K Hold
5,910
0.1% 80
2024
Q2
$245K Hold
5,910
0.11% 82
2024
Q1
$242K Hold
5,910
0.12% 82
2023
Q4
$219K Hold
5,910
0.11% 93
2023
Q3
$206K Hold
5,910
0.13% 80
2023
Q2
$209K Hold
5,910
0.12% 90
2023
Q1
$208K Buy
+5,910
New +$204K 0.12% 99
2022
Q3
Sell
-5,910
Closed -$206K 112
2022
Q2
$206K Hold
5,910
0.22% 103
2022
Q1
$223K Hold
5,910
0.18% 124
2021
Q4
$232K Hold
5,910
0.14% 160
2021
Q3
$223K Hold
5,910
0.14% 174
2021
Q2
$222K Hold
5,910
0.13% 186
2021
Q1
$215K Buy
+5,910
New +$208K 0.15% 171

Other funds holding DBEF

Vigilare Wealth Management's DBEF Position: Q2 2026 in Review

Vigilare Wealth Management held its Xtrackers MSCI EAFE Hedged Equity ETF (DBEF) position steady in Q2 2026 at 5,910 shares worth $323K. The position accounts for 0.1% of the portfolio, ranked #92.

Vigilare Wealth Management first reported a position in DBEF in Q1 2021 and has held it in 20 quarters since. 444 funds tracked by Wall St. Rank hold DBEF as of Q2 2026.

  • Vigilare Wealth Management held 5,910 shares of Xtrackers MSCI EAFE Hedged Equity ETF worth $323K as of Q2 2026.
  • Vigilare Wealth Management left its Xtrackers MSCI EAFE Hedged Equity ETF share count unchanged in Q2 2026.
  • Xtrackers MSCI EAFE Hedged Equity ETF made up 0.1% of Vigilare Wealth Management's portfolio in Q2 2026, its #92 holding.
  • Vigilare Wealth Management first reported a position in Xtrackers MSCI EAFE Hedged Equity ETF in Q1 2021 and has held it in 20 quarters since.
  • 444 funds tracked by Wall St. Rank held Xtrackers MSCI EAFE Hedged Equity ETF as of Q2 2026.

Based on Vigilare Wealth Management's 13F filing for Q2 2026, filed 6 Jul 2026.